| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/30/2005 | WO2005035504A3 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 06/30/2005 | WO2005033099A3 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
| 06/30/2005 | WO2005032493A8 Amide compounds as ion channel ligands and uses thereof |
| 06/30/2005 | WO2005012914A3 Method for characterising polypeptides by maldi-tof mas spectrometry |
| 06/30/2005 | WO2004087649A3 Benodiazepine spirohydantoin cgrp receptor antagonists |
| 06/30/2005 | WO2004055009A8 Novel compounds having selective inhibiting efect at gsk3 |
| 06/30/2005 | WO2004055006A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | US20050143578 Compounds and methods |
| 06/30/2005 | US20050143446 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 06/30/2005 | US20050143440 Excellent hypoglycemic agents for treating hyperglycemia, dyslipidemia, hypercholesterolemia, noninsulin-dependent type II diabetes, obesity, glucose intolerance, cardiovascular diabetic complications; reduced side effects due to absence of serotonin reuptake inhibition; imidazoline receptor pathologies |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143427 treating bone disorders of joint cartilage damage, osteoarthritis, rheumatoid arthritis, or joint inflammation, and pain associate with; antiinflammatory agent; 1-methyl-octahydroindole-2-carboxylic acid |
| 06/30/2005 | US20050143405 Dipeptidyl peptidase inhibitors that lower plasma glucose; treatment and prophylaxis of diabetes, non-insulin dependent diabetes; 2-amino-3aminomethyl-4-phenylpyridines |
| 06/30/2005 | US20050143403 Substituted pyrimidinones and pyrimidinthiones |
| 06/30/2005 | US20050143392 3,1'-didehydro-3[2"(3'",3'"-dimethyl-prop-2-enyl)-3"-indolyl methylene]-6-methylpiperazine-2,5-dione; Fermentation of a mangrove-associated fungus Penicillium chrysogenum; solvent extraction; antibiotic against Gram-negative Vibrio cholerae; alternative to Tetracycline |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143387 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints |
| 06/30/2005 | US20050143383 Benzo[a]phenazine-11-carboxamide derivative used as fungicide, bactericide, inhibitors of topoisomerase for treating cancer |
| 06/30/2005 | DE10354584A1 Kationische Diaminopyrazole, ein Verfahren zu deren Herstellung und diese Verbindungen enthaltende Färbemittel Cationic diaminopyrazoles, a process for their preparation and compositions containing these compounds colorant |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549167A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 06/30/2005 | CA2548388A1 Heterocyclic aspartyl protease inhibitors |
| 06/30/2005 | CA2545767A1 Novel compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions |
| 06/30/2005 | CA2545294A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 06/29/2005 | EP1548009A2 Process for the preparation of benzylimidazole derivatives and for losartan |
| 06/29/2005 | EP1547616A1 Preventive and/or therapeutic drugs for itch |
| 06/29/2005 | EP1546162A2 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 06/29/2005 | EP1546158A1 Azole derivatives as antifungal agents |
| 06/29/2005 | EP1546144A2 Delta1 pyrrolines used as pesticides |
| 06/29/2005 | EP1546141A1 Isoxazoles and their use in the treatment of ischemic diseases |
| 06/29/2005 | EP1546135A2 Novel synthesis of irbesartan |
| 06/29/2005 | EP1546134A1 Piperazine substituted aryl benzodiazepines |
| 06/29/2005 | EP1546132A1 Pyrazole derivatives as reverse transcriptase inhibitors |
| 06/29/2005 | EP1546121A1 Substituted triazine kinase inhibitors |
| 06/29/2005 | EP1546117A2 Protein kinase inhibitors and uses thereof |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546113A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 06/29/2005 | EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 06/29/2005 | EP1546097A1 Pyrrole derivatives as antimycobacterial compounds |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1545543A2 Novel tyrosine kinases inhibitors |
| 06/29/2005 | EP1545532A2 Heterocyclic compounds |
| 06/29/2005 | EP1545528A2 Indole-type derivatives as inhibitors of p38 kinase |
| 06/29/2005 | EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS |
| 06/29/2005 | EP1545515A1 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| 06/29/2005 | EP1545510A1 Substituted phenylindoles for the treatment of hiv |
| 06/29/2005 | CN1633433A N-aroyl cyclic amines |
| 06/29/2005 | CN1633431A 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors |
| 06/29/2005 | CN1633430A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders |
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/29/2005 | CN1633418A Arylalkane-sulfonamides having endothelin-antagonist activity |
| 06/29/2005 | CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 06/29/2005 | CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/29/2005 | CN1208318C Cycloamine CCR5 receptor antagonists |
| 06/28/2005 | US6911465 For treating inflammatory diseases including rheumatoid arthritis, glomerular nephritides, lung fibrosis, restenosis, alveolitis, asthma, psoriasis, inflammatory bowel disease, multiple sclerosis and brain trauma, stroke, ischemia |
| 06/28/2005 | US6911463 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity |
| 06/28/2005 | US6911462 Benzimidazole compounds for regulating IgE |
| 06/28/2005 | US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse |
| 06/28/2005 | US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 |
| 06/28/2005 | US6911446 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/23/2005 | WO2005056547A2 Quinoxalines useful as inhibitors of protein kinases |
| 06/23/2005 | WO2005056546A1 Keto lactam compounds and use thereof |
| 06/23/2005 | WO2005056535A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 06/23/2005 | WO2005056533A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 06/23/2005 | WO2005056508A1 Method for the production of tetrahydrogeranylacetone |
| 06/23/2005 | WO2005056015A1 Substituted piperazines |
| 06/23/2005 | WO2005056004A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 06/23/2005 | WO2005056003A1 Dpp-iv inhibitors |
| 06/23/2005 | WO2005042444A3 Platinum complex and luminescent element |
| 06/23/2005 | WO2005041888A3 Pyrimidin-4-one compounds, compositions and methods |
| 06/23/2005 | WO2005034870A3 Amide compounds and ion channel ligands and uses thereof |
| 06/23/2005 | WO2005033930A3 Process for upgrading naphtha |
| 06/23/2005 | WO2005033105A3 Vanilloid receptor ligands and their use in treatments |
| 06/23/2005 | WO2005014584A9 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis |
| 06/23/2005 | US20050137243 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 06/23/2005 | US20050137241 For therapy of epilepsy, epileptogenesis, seizure disorders, convulsions, dyskinesia and neuropathic pain in a mammal |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137213 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137207 Inhibitor of prenylprotein tranferase for cancer and tumor treatment |
| 06/23/2005 | US20050137202 Heterocyclic compounds as antiinflammatory agents and cyclooxygenase inhibitors |
| 06/23/2005 | US20050137196 Medical devices employing triazine compounds and compositions thereof |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/23/2005 | US20050137187 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 06/23/2005 | US20050137139 Peptidomimetic compounds, useful as antiviral agents; used to inhibit HCV replication and to lessen the risk of or the severity of HCV infection |
| 06/23/2005 | US20050136014 esters with with C16 to C50 alcohols and/or siloxane derivatives; increased water resistance, increased stability, improved permanence |
| 06/23/2005 | US20050135737 Optical interleaver |
| 06/23/2005 | CA2548742A1 Dpp-iv inhibitors |
| 06/23/2005 | CA2548426A1 Substituted piperazines |
| 06/23/2005 | CA2548276A1 Keto lactam compounds and use thereof |
| 06/23/2005 | CA2548262A1 Method for the production of tetrahydrogeranylacetone |
| 06/23/2005 | CA2548172A1 Quinoxalines useful as inhibitors of protein kinases |
| 06/23/2005 | CA2547573A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 06/23/2005 | CA2547410A1 1,2,3-triazole amide derivatives as inhibitors of cytokie production |
| 06/23/2005 | CA2547391A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 06/22/2005 | EP1544198A1 A process for the preparation of crystalline losartan potassium |
| 06/22/2005 | EP1542993A1 Piperazine derivatives and methods of use |